• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics.微小RNA-122与肝细胞癌：从分子生物学到治疗学
EBioMedicine. 2018 Nov;37:17-18. doi: 10.1016/j.ebiom.2018.10.032. Epub 2018 Oct 15.
2
Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.鉴定人肝和肝癌中的 miRNA 组揭示 miR-199a/b-3p 是肝癌的治疗靶点。
Cancer Cell. 2011 Feb 15;19(2):232-43. doi: 10.1016/j.ccr.2011.01.001.
3
The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma.miRNA 替代疗法治疗肝细胞癌的前景。
Curr Gene Ther. 2019;19(5):290-304. doi: 10.2174/1566523219666191023101433.
4
LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.长链非编码 RNA HOTAIR 通过 DNA 甲基化在肝癌中表观遗传抑制 miR-122 的表达。
EBioMedicine. 2018 Oct;36:159-170. doi: 10.1016/j.ebiom.2018.08.055. Epub 2018 Sep 5.
5
Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.长链非编码RNA GIHCG通过表观遗传调控miR-200b/a/429促进肝细胞癌进展。
J Mol Med (Berl). 2016 Nov;94(11):1281-1296. doi: 10.1007/s00109-016-1442-z. Epub 2016 Jul 5.
6
Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.长链非编码RNA、基因组元件的甲基化及其在肝细胞癌中新兴的相互作用
Cancer Lett. 2016 Sep 1;379(2):239-44. doi: 10.1016/j.canlet.2015.08.008. Epub 2015 Aug 14.
7
Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy.长链非编码RNA TUG1-微小RNA-328-3p-SRSF9信使核糖核酸轴在肝细胞癌中的异常调控：一个有前景的预后和治疗靶点
Mol Cancer. 2022 Feb 4;21(1):36. doi: 10.1186/s12943-021-01493-6.
8
LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.长链非编码 RNA TUG1 通过与 miR-144 相互作用，激活肝癌中的 JAK2/STAT3 通路，促进增殖、迁移和肿瘤发生。
Int J Biochem Cell Biol. 2018 Aug;101:19-28. doi: 10.1016/j.biocel.2018.05.010. Epub 2018 May 20.
9
[Advances in therapeutic regulation of long non-coding RNA for treating hepatocellular carcinoma].[长链非编码RNA治疗性调控在肝细胞癌治疗中的研究进展]
Zhonghua Gan Zang Bing Za Zhi. 2014 Jun;22(6):470-1.
10
Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.肝细胞癌患者分子标志物的最新进展。
Expert Rev Mol Diagn. 2019 Aug;19(8):725-738. doi: 10.1080/14737159.2019.1638254. Epub 2019 Jul 3.

引用本文的文献

1
MicroRNA-206 as a promising epigenetic approach to modulate tumor-associated macrophages in hepatocellular carcinoma.miRNA-206 作为一种有前途的表观遗传方法，可调节肝癌中的肿瘤相关巨噬细胞。
World J Gastroenterol. 2024 Nov 7;30(41):4503-4508. doi: 10.3748/wjg.v30.i41.4503.
2
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122.循环 microRNAs 在肝脏疾病和 HCC 中的作用：聚焦于 miR-122。
Genes (Basel). 2024 Oct 12;15(10):1313. doi: 10.3390/genes15101313.
3
CMC: Cancer miRNA Census - a list of cancer-related miRNA genes.CMC：癌症 miRNA 目录——癌症相关 miRNA 基因列表。
Nucleic Acids Res. 2024 Feb 28;52(4):1628-1644. doi: 10.1093/nar/gkae017.
4
Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches.调控肝细胞癌上皮-间充质转化的机制和靶向治疗方法。
Adv Exp Med Biol. 2024;1450:93-102. doi: 10.1007/5584_2023_781.
5
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.浅析 microRNAs 在肝细胞癌中的涌现角色：未来的诊断和治疗方法。
Int J Mol Sci. 2023 Apr 12;24(8):7168. doi: 10.3390/ijms24087168.
6
LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma.长链非编码 RNA RPPH1 作为 miR-122 的分子海绵调节肝细胞癌中的 Wnt1/β-catenin 信号通路。
Int J Med Sci. 2023 Jan 1;20(1):23-34. doi: 10.7150/ijms.68778. eCollection 2023.
7
During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study.丙型肝炎病毒直接抗病毒药物治疗期间，血浆Mip1B、IP10和微小RNA谱与随后肝细胞癌的诊断显著相关：一项初步研究。
Biology (Basel). 2022 Aug 25;11(9):1262. doi: 10.3390/biology11091262.
8
Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients.miR-122、miR-483和miR-335表达水平作为埃及患者丙型肝炎病毒相关肝细胞癌（HCC）潜在标志物的意义
Front Mol Biosci. 2022 May 16;9:864839. doi: 10.3389/fmolb.2022.864839. eCollection 2022.
9
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy.间充质干细胞衍生的外泌体作为 miRNA 在癌症治疗中递送的新型载体。
Cancer Gene Ther. 2022 Aug;29(8-9):1105-1116. doi: 10.1038/s41417-022-00427-8. Epub 2022 Jan 26.
10
HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site.乙肝病毒整合在插入位点诱导宿主与病毒基因组功能之间的复杂相互作用。
J Clin Transl Hepatol. 2021 Jun 28;9(3):399-408. doi: 10.14218/JCTH.2021.00062. Epub 2021 Apr 25.

本文引用的文献

1
LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.长链非编码 RNA HOTAIR 通过 DNA 甲基化在肝癌中表观遗传抑制 miR-122 的表达。
EBioMedicine. 2018 Oct;36:159-170. doi: 10.1016/j.ebiom.2018.08.055. Epub 2018 Sep 5.
2
Targeted imaging and induction of apoptosis of drug-resistant hepatoma cells by miR-122-loaded graphene-InP nanocompounds.载有miR-122的石墨烯-InP纳米复合物对耐药肝癌细胞的靶向成像及凋亡诱导作用
J Nanobiotechnology. 2017 Jan 23;15(1):9. doi: 10.1186/s12951-016-0237-2.
3
microRNA Therapeutics in Cancer - An Emerging Concept.微小 RNA 治疗癌症——一个新兴概念。
EBioMedicine. 2016 Oct;12:34-42. doi: 10.1016/j.ebiom.2016.09.017. Epub 2016 Sep 20.
4
Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma.微小RNA-122靶向PCDH20基因赋予肝癌对5-氟尿嘧啶的抗性。
Am J Cancer Res. 2016 Aug 1;6(8):1681-94. eCollection 2016.
5
Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.基于MS2病毒样颗粒表面展示细胞穿透肽TAT的新型miR-122递送系统用于肝细胞癌
Oncotarget. 2016 Sep 13;7(37):59402-59416. doi: 10.18632/oncotarget.10681.
6
Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.丙型肝炎病毒感染患者血清微小RNA表达谱失调及潜在生物标志物
Int J Med Sci. 2015 Jul 16;12(7):590-8. doi: 10.7150/ijms.11525. eCollection 2015.
7
DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.基于 DNA 甲基化的肝细胞癌预后和表皮驱动因素。
Hepatology. 2015 Jun;61(6):1945-56. doi: 10.1002/hep.27732. Epub 2015 Mar 18.
8
Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis.miR-122 的沉默是非酒精性脂肪性肝炎向肝癌发展过程中的早期事件。
Cancer Sci. 2014 Oct;105(10):1254-60. doi: 10.1111/cas.12498. Epub 2014 Sep 25.
9
Evaluation of miR-122-regulated suicide gene therapy for hepatocellular carcinoma in an orthotopic mouse model.miR-122 调控自杀基因治疗肝癌的原位小鼠模型评价。
Chin J Cancer Res. 2013 Dec;25(6):646-55. doi: 10.3978/j.issn.1000-9604.2013.11.07.
10
Treatment of HCV infection by targeting microRNA.针对 microRNA 治疗 HCV 感染。
N Engl J Med. 2013 May 2;368(18):1685-94. doi: 10.1056/NEJMoa1209026. Epub 2013 Mar 27.

miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics.

作者信息

Fu Xiao, Calin George A

机构信息

Departments of Experimental Therapeutics and Leukemia, MD Anderson Cancer Center, Houston, TX, United States; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Departments of Experimental Therapeutics and Leukemia, MD Anderson Cancer Center, Houston, TX, United States; The Center for RNA Interference and Non-Coding RNAs, MD Anderson Cancer Center, Houston, TX, United States.

出版信息

EBioMedicine. 2018 Nov;37:17-18. doi: 10.1016/j.ebiom.2018.10.032. Epub 2018 Oct 15.

DOI:10.1016/j.ebiom.2018.10.032
PMID:30337246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6284505/
Abstract
摘要